[ad_1]
STOCKHOLM, Nov 23 (Reuters) – Denmark’s Novo Nordisk (NOVOb.CO) said on Thursday it would invest more than 16 billion crowns ($2.34 billion) in the expansion of production facilities in Chartres in France.
Reporting by Anna Ringstrom, editing by Terje Solsvik
[ad_2]
Source link